Startup Ideas Bank

Automating pre-auth for radiology and oncology is a solid, albeit complex, SaaS play in healthcare.

AI roast score: 85/100 (A-)

The idea

380 hospitals using this? $9.1M ARR and just raised $18M Series A. This isn't a pitch deck fantasy; it's a revenue-generating machine tackling a painful healthcare bottleneck. Now, can they conquer global compliance? That's the real test.

In the founder's own words

We're building a clinical workflow platform that helps US hospital networks automate insurance pre-authorization for radiology and oncology orders. We sell to enterprise hospital systems on annual subscriptions averaging $24k per facility, currently profitable with 380 hospitals across 14 states and $9.1M ARR. We just closed an $18M Series A and are expanding into Canada and the UK next year. Main worry is whether we can keep our HIPAA + state-by-state compliance posture as we scale internationa

The roast

Alright, let's cut through the noise. You're not reinventing the wheel, but you're making a damn important wheel turn faster. Automating pre-authorizations for radiology and oncology is a brutal, necessary grind. You've clearly found a pain point that hospital networks are willing to pay good money to fix, evidenced by your $9.1M ARR and a plump $18M Series A. This isn't a vanity project; it's a cash-generating engine. The fact that you're already profitable with this many facilities shows a strong product-market fit and an execution capability that most startups only dream of. However, let's not pretend this is easy. HIPAA and state-by-state compliance are a labyrinth, and expanding internationally means navigating entirely new mazes of regulations. Your biggest challenge isn't the tech; it's the legal and regulatory gymnastics required to scale across borders. Don't get complacent on that front, or your growth will hit a brick wall faster than you can say 'FDA approval'.

Red flags

Verdict

Double down on your compliance automation play, but be ruthlessly pragmatic about the international expansion timeline and associated risks.

Roast your own startup idea →